Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Immunity|July 21, 2017
The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected CellsHong-Sheng Dai, Nathaniel Griffin, Chelsea Bolyard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor MicroenvironmentW Hans Meisen, Eric S Wohleb, Alena Cristina Jaime-Ramirez, et al.
Molecular Therapy Oncolytics|January 1, 2020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal SurvivalPaola Sette, Nduka Amankulor, Aofei Li, et al.
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapyJianying Li, Anjun Ma, Ruohan Zhang, et al.
The Journal of Clinical Investigation|May 24, 2024
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapyLei Zhou, Maria Velegraki, Yi Wang, et al.
Cancers|April 29, 2020
Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell ActivationMitra Nair, Maninder Khosla, Yoshihiro Otani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2014
Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effectsJi Young Yoo, Brian S Hurwitz, Chelsea Bolyard, et al.
Journal for Immunotherapy of Cancer|January 4, 2024
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancerNo-Joon Song, Karthik B Chakravarthy, Hyeongseon Jeon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Alena Cristina Jaime-Ramirez, Chelsea Bolyard, et al.
Pageof 3